| Study Protocol Number | Study Title and Description |
|---|---|
| 24-1750 |
Oral Venetoclax Combined with Chemotherapy to Treat Children with Acute Myeloid Leukemia
In this study, we want to learn whether adding a new oral drug called Venetoclax to standard chemotherapy affects how long children and young adults with acute myeloid leukemia (AML) stay in remission and what side effects they experience. |